Literature DB >> 22762053

Transcranial surgery through pterional approach for removal of cranio-orbital tumors by an interdisciplinary team of nurosurgeons and ophthalmologists.

Yan Liu1, Jiang-Rong Ma, Xue-Liang Xu.   

Abstract

AIM: To investigate the specialty of transcranial surgery through pterional approach for removal of cranio-orbital tumors, introduce the ophthalmological experiences of entering the orbit to reduce the incidence rate of associated complications of this operation.
METHODS: We performed a retrospective analysis of a series of 37 cases involving patients who underwent transcranial surgery through pterional approach for treatment of cranio-orbital tumors in our department in the past 8 years. Pterion approach craniotomy was performed to all patients. After removing tumors in the skull by the neurosurgeon, ophthalmologist removed tumors in orbit. We took measures below to decrease complications, including grounding optic canal through an abrasive drilling when necessary, hanging various extraocular muscles to be exposed for protection, refrigerating by refrigeration heads to remove tumors, at last sewing up orbit septum after surgery.
RESULTS: Tumors were removed completely in 32 cases, and incomplete in 5 cases due to extensive invasion into the cavernous sinus or sphenoid sinus. Of all the cases, benign tumors were demonstrated in 28 cases (75.6%, 28/37) and malignant in 9(24.3%, 9/37). The most common lesion type was meningioma in 11 cases (29.7%, 11/37). Extraocular muscles (EOM) impairment, occurring in 21 cases (56.7%, 21/37), was the most frequent postoperative complication. The most serious consequence was vision loss occurred in 4 cases (10.8%, 4/37). Other complications, such as 11 cases of transient blepharoptosis 29.7% (11/37), 5 cases of mydriasis in 13.5% (5/7); 2 cases of cerebrospinal rhinorrhea in 5.4% (2/37).
CONCLUSION: Cranio-orbital tumors can be removed completely using transcranial approach, and the pterional approach offers excellent exposure. Cooperation of interdisciplinary team of neurosurgeons and ophthalmologists conduces to full use of respective professional advantages. The experience of ophthalmic operation technology can decrease occurrence of ocular complications after surgery.

Entities:  

Keywords:  complications; cranio-orbital tumors; ophthalmic operational experiences; transcranial operation

Year:  2012        PMID: 22762053      PMCID: PMC3359041          DOI: 10.3980/j.issn.2222-3959.2012.02.19

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  22 in total

1.  Cranio-orbital-temporal neurofibromatosis: are we treating the whole problem?

Authors:  R J Havlik; J Boaz
Journal:  J Craniofac Surg       Date:  1998-11       Impact factor: 1.046

2.  Anterolateral mini fronto-orbito-zygomatic craniotomy via an eyebrow incision in pediatrics: technical notes and evaluation.

Authors:  Hassan I El Shafei
Journal:  Pediatr Neurosurg       Date:  2012-02-03       Impact factor: 1.162

3.  [The complications and affect factors in the surgery of orbital tumor].

Authors:  Xueliang Xu; Chengye Wang; Shuangzhen Liu; Qian Xiang
Journal:  Yan Ke Xue Bao       Date:  2004-12

4.  Lateral supraorbital approach as an alternative to the classical pterional approach.

Authors:  J Hernesniemi; K Ishii; M Niemelä; M Smrcka; L Kivipelto; M Fujiki; H Shen
Journal:  Acta Neurochir Suppl       Date:  2005

5.  [Cranio-orbital zygomatic extradural approach for cavernous sinus or Meckel's cave tumors].

Authors:  T Kinjo; J Mukawa; S Mekaru; H Koga
Journal:  No Shinkei Geka       Date:  1996-06

6.  The surgical management of cranio-orbital neurofibromatosis.

Authors:  D Krastinova-Lolov; F Hamza
Journal:  Ann Plast Surg       Date:  1996-03       Impact factor: 1.539

7.  Tumors of the orbit. Pitfalls of the surgical approach in 37 children with orbital tumor.

Authors:  J K Kang; I W Lee; S S Jeun; Y K Choi; C K Jung; J H Yang; D S Kim
Journal:  Childs Nerv Syst       Date:  1997-10       Impact factor: 1.475

Review 8.  Skull base approaches in neurosurgery.

Authors:  Martin Scholz; Richard Parvin; Jost Thissen; Catharina Löhnert; Albrecht Harders; Klaus Blaeser
Journal:  Head Neck Oncol       Date:  2010-07-05

Review 9.  Orbitotemporal neurofibromatosis: classification and treatment.

Authors:  Melanie H Erb; Nicolas Uzcategui; Robert F See; Michael A Burnstine
Journal:  Orbit       Date:  2007-12

10.  Deep transorbital approach to the apex and cavernous sinus.

Authors:  R A Goldberg; N Shorr; A C Arnold; G H Garcia
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1998-09       Impact factor: 1.746

View more
  5 in total

1.  Restrictive Strabismus Following Frontotemporal-orbitozygomatic Craniotomy.

Authors:  Oluwatobi O Idowu; Evan Kalin-Hajdu; F Lawson Grumbine; Robert C Kersten; Michael McDermott; M Reza Vagefi
Journal:  Cureus       Date:  2017-12-11

2.  A simple classification of cranial-nasal-orbital communicating tumors that facilitate choice of surgical approaches: analysis of a series of 32 cases.

Authors:  Yue-Fei Deng; Bing-Xi Lei; Mei-Guang Zheng; Yi-Qing Zheng; Wei-Liang Chen; Yu-Qing Lan
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-26       Impact factor: 2.503

3.  Primary orbital tumors: a review of 122 cases during a 23-year period: a histo-clinical study in material from the ENT Department of the Medical University of Silesia.

Authors:  Jarosław Markowski; Estera Jagosz-Kandziora; Wirginia Likus; Jacek Pająk; Ewa Mrukwa-Kominek; Jarosław Paluch; Włodzimierz Dziubdziela
Journal:  Med Sci Monit       Date:  2014-06-16

4.  Cranio-Orbital Tumors: Clinical Results and A Surgical Approach.

Authors:  Mustafa Kılıç; Barış Özöner; Levent Aydın; Burak Özdemir; İlhan Yılmaz; Ahmet Murat Müslüman; Adem Yılmaz; Halit Çavuşoğlu; Yunus Aydın
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2019-08-27

5.  Cranial CT scan evaluation of morphological variations and location of pterion in Pakistani male population for lateral neurosurgical approach.

Authors:  Aisha Rafi; Sana Sayeed; Muhammad Idrees Anwar
Journal:  Pak J Med Sci       Date:  2020 Mar-Apr       Impact factor: 1.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.